1-7 of 7
Amir Hossein Daneshmanesh, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

First-in-Class Oral Small Molecule Against the Tyrosine Kinase ROR1 (KAN0439834) Induced Significant Apoptosis of Chronic Lymphocytic Leukemia Cells

Mohammad Hojjat-Farsangi, MSc, PhD Assist. Prof., Amir Hossein Daneshmanesh, MD PhD, Fariba Mozaffari, MSc, PhD, Lotta Hansson, Jan Vågberg, PhD, Styrbjörn Byström, PhD, Elisabeth Olsson, PhD, Charlotta Löfberg, PhD, Charlotta Carina Norström, PhD, Johan Schultz, PhD, Martin Norin, PhD, Thomas Olin, PhD, Anders Österborg, MD PhD Prof., Ali Moshfegh, PhD, Hakan Mellstedt, MD PhD Prof.
Journal: Blood
Blood (2017) 130 (Supplement 1): 4320.
https://doi.org/10.1182/blood.V130.Suppl_1.4320.4320
Published: 2017
Journal Articles

First-in-Class ROR1 Small Molecule Inhibitor (KAN0439834) Downregulated Wnt-Canonical and Non-Canonical Signaling Pathways and Induced Apoptosis of CLL Cells

Mohammad Hojjat-Farsangi, PhD, Ali Moshfegh, PhD, Amir Hossein Daneshmanesh, MD PhD, Jan Vågberg, Byström Styrbjörn, Johan Schultz, Elisabeth Olsson, Charlotta Löfberg, Carina Norström, Martin Norin, Thomas Olin, PhD, Anders Österborg, MD PhD, Håkan Mellstedt, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2912.
https://doi.org/10.1182/blood.V126.23.2912.2912
Published: 2015
Journal Articles

Monoclonal Antibody Against ROR1 in Chronic Lymphocytic Leukemia Cells Induced Apoptosis Via PI3-Kinase/AKT/CREB Pathway

Amir Hossein Daneshmanesh, MD, PhD, Mohammad Hojjat-Farsangi, PhD, Asa Sandin, PhD, Abdul Salam Khan, Msc, Ali Moshfegh, PhD, Mahmood Jeddi-Tehrani, PhD, Anders Österborg, MD, PhD, Håkan Mellstedt, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1769.
https://doi.org/10.1182/blood.V120.21.1769.1769
Published: 2012
Journal Articles

Phosphorylation of Receptor Tyrosine Kinase ROR1 At Tyrosine 641, 646 and Serine 652 residues Might Be of Importance for the Survival of CLL Leukemic Cells

Mohammad Hojjat-Farsangi, Ph.D, Amir Hossein Daneshmanesh, MD, PhD, Martin Norin, Ph.D, Åsa Sandin, Ph.D, Abdul Salam Khan, Msc, Ali Moshfegh, PhD, Eva Rossmann, MD, Ph.D, Anders Osterborg, MD, PhD, Hakan Mellstedt, MD, Ph.D
Journal: Blood
Blood (2012) 120 (21): 3885.
https://doi.org/10.1182/blood.V120.21.3885.3885
Published: 2012
Journal Articles

Patients with Chronic Lymphocyte Leukemia (CLL) Have Naturally Occurring Antibodies Against the Receptor Tyrosine Kinase (ROR1)

Mohammad Hojjat-Farsangi, PhD, Fariba Mozaffari, Ph.D, Amir Hossein Daneshmanesh, MD, Ph.D, Anders Osterborg, MD, PhD, Fazel Shokri, Ph.D, Håkan Mellstedt, MD, Ph.D
Journal: Blood
Blood (2011) 118 (21): 1771.
https://doi.org/10.1182/blood.V118.21.1771.1771
Published: 2011
Journal Articles

Ror1 Targeting Monoclonal Antibodies Induced Apoptosis of Chronic Lymphocytic Leukemia Cells– A Potential Novel Therapeutic Approach

Hodjattallah Rabbani, PhD, Amir Hossein Daneshmanesh, MD, Abdul Salam Khan, MSc, Mohammad Hojjat-Farsangi, PhD, Mahmood Jeddi-Tehrani, PhD, Mohammad Mehdi Akhondi, PhD, Anders Österborg, MD, PhD, Fazel Shokri, PhD, Håakan Mellstedt, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 916.
https://doi.org/10.1182/blood.V116.21.916.916
Published: 2010
Journal Articles

T Cells From CLL Patients Recognize Spontaneously Peptides Derived of the Receptor Tyrosine Kinase Ror1

Mohammad Hojjat -Farsangi, Ph.D, Amir Hossein Daneshmanesh, MD, Mahmood Jeddi-Tehrani, Ph.D, Anders Osterborg, MD, PhD, Fazel Shokri, Ph.D, Håkan Mellstedt, MD, Ph.D, Hodjattallah Rabbani, Ph.D
Journal: Blood
Blood (2010) 116 (21): 3603.
https://doi.org/10.1182/blood.V116.21.3603.3603
Published: 2010